Fidelity Investments’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $281K | Buy |
+144,239
| New | +$281K | ﹤0.01% | 3185 |
|
|
2022
Q4 | – | Sell |
-72,217
| Closed | -$394K | – | 5474 |
|
|
2022
Q3 | $394K | Hold |
72,217
| – | – | ﹤0.01% | 2853 |
|
|
2022
Q2 | $322K | Hold |
72,217
| – | – | ﹤0.01% | 2985 |
|
|
2022
Q1 | $641K | Hold |
72,217
| – | – | ﹤0.01% | 2910 |
|
|
2021
Q4 | $637K | Hold |
72,217
| – | – | ﹤0.01% | 2746 |
|
|
2021
Q3 | $823K | Hold |
72,217
| – | – | ﹤0.01% | 2722 |
|
|
2021
Q2 | $1.21M | Buy |
72,217
+55,550
| +333% | +$933K | ﹤0.01% | 2630 |
|
|
2021
Q1 | $601K | Hold |
16,667
| – | – | ﹤0.01% | 2661 |
|
|
2020
Q4 | $690K | Buy |
+16,667
| New | +$690K | ﹤0.01% | 2595 |
|